Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/191809
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: Pathogenic PTEN germline variants cause PTEN Hamartoma Tumor Syndrome (PHTS), a rare disease with a variable genotype and phenotype. Knowledge about these spectra and genotype-phenotype associations could help diagnostics and potentially lead to personalized care. Therefore, we assessed the PHTS genotype and phenotype spectrum in a large cohort study. Methods: Information was collected of 510 index patients with pathogenic or likely pathogenic (LP/P) PTEN variants (n = 467) or variants of uncertain significance. Genotype-phenotype associations were assessed using logistic regression analyses adjusted for sex and age.Results: At time of genetic testing, the majority of children (n = 229) had macrocephaly (81%) or developmental delay (DD, 61%), and about half of the adults (n = 238) had cancer (51%), macrocephaly (61%), or cutaneous pathology (49%). Across PTEN, 268 LP/P variants were identified, with exon 5 as hotspot. Missense variants (n = 161) were mainly located in the phosphatase domain (PD, 90%) and truncating variants (n = 306) across all domains. A trend towards 2 times more often truncating variants was observed in adults (OR = 2.3, 95%CI = 1.5-3.4) and patients with cutaneous pathology (OR = 1.6, 95%CI = 1.1-2.5) or benign thyroid pathology (OR = 2.0, 95%CI = 1.1-3.5), with trends up to 2-4 times more variants in PD. Whereas patients with DD (OR = 0.5, 95%CI = 0.3-0.9) or macrocephaly (OR = 0.6, 95%CI = 0.4-0.9) had about 2 times less often truncating variants compared to missense variants. In DD patients these missense variants were often located in domain C2.Conclusion: The PHTS phenotypic diversity may partly be explained by the PTEN variant coding effect and the combination of coding effect and domain. PHTS patients with early-onset disease often had missense variants, and those with later-onset disease often truncating variants.
Matèries
Matèries (anglès)
Citació
Citació
HENDRICKS, Linda a.j., HOOGERBRUGGE, Nicoline, VENSELAAR, Hanka, ARETZ, Stefan, SPIER, Isabel, LEGIUS, Eric, BREMS, Hilde, DE PUTTER, Robin, CLAES, Kathleen b.m., EVANS, D. gareth, WOODWARD, Emma r., GENUARDI, Maurizio, BRUGNOLETTI, Fulvia, VAN IERLAND, Yvette, DIJKE, Kim, THAM, Emma, TESI, Bianca, SCHUURS HOEIJMAKERS, Janneke h.m., BRANCHAUD, Maud, SALVADOR, Héctor, JAHN, Arne, SCHNAITER, Simon, ANASTASIADOU, Violetta c., BRUNET, Joan, OLIVEIRA, Carla, ROHT, Laura, BLATNIK, Ana, IRMEJS, Arvids, MENSENKAMP, Arjen r., VOS, Janet r., DUIJKERS, Floor, GILTAY, Jacques c., VAN HEST, Liselotte p., KLEEFSTRA, Tjitske, LETER, Edward m., NIELSEN, Maartje, NIJMEIJER, Sebastiaan w.r., OLDERODE-BERENDS, Maran j. w.. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort. _European Journal of Medical Genetics_. 2022. Vol. 65, núm. 12, pàgs. 104632. [consulta: 21 de gener de 2026]. ISSN: 1878-0849. [Disponible a: https://hdl.handle.net/2445/191809]